Stock QLGN QUALIGEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Qualigen Therapeutics, Inc.

Equities

QLGN

US74754R2022

Delayed Nasdaq
Other stock markets
 15:45:21 13/05/2024 BST 		5-day change 1st Jan Change
0.272 USD -4.39% Intraday chart for Qualigen Therapeutics, Inc. -7.14% -50.55%
04-16 Marizyme Enters into Co-Development Agreement with Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft? CI
04-08 Qualigen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. QLGN Stock
  4. News Qualigen Therapeutics, Inc.
  5. Official Publications